Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-03-12 @ 12:01 PM
Study NCT ID:
NCT02625168
Status:
COMPLETED
Last Update Posted:
2015-12-09
First Post:
2015-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLC
Sponsor:
The University of Hong Kong
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-02
First Submit QC Date:
None
Study First Post Date:
2015-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-06
Last Update Post Date:
2015-12-09
Last Update Post Date Type:
ESTIMATED